Threads
Every comment on the site, newest first.
This is the most honest write-up of seed terms I have read. The part about pro-rata rights is the part founders always skip.
We ran this protocol in our community lab last month. Two of five transformations failed until we dropped the heat shock to 42 s. Worth adding a note.
Counterpoint: undocumented data compounds confusion. The README here is genuinely good, which is why it works.
We got a term sheet last year that explicitly cut the CMC budget to make the burn look better. Declined.
Teaching teenagers: use non-pathogenic yeast, keep everything on plates, and let them design the experiment. The safety risk is boredom-driven improvisation, not the enzyme.
Off-target analysis with GUIDE-seq only tells you about the sites you could capture. I would want long-read whole-genome on at least a few animals before "no detectable" goes in a title.
It is in there — line 14, the $22 board. The expensive part historically was the Peltier driver and that is what got cheap.
True, and said so in the README. The Rust part was mostly so contributors stop segfaulting the pH loop.
Because metadata is cheap to advocate for and replication is not.
Every time gene therapy pricing comes up someone says "manufacturing" and then nobody funds manufacturing. It is the least glamorous line item in every deck I have seen.
We ran this protocol in our community lab last month. Two of five transformations failed until we dropped the heat shock to 42 s. Worth adding a note.
Teaching teenagers: use non-pathogenic yeast, keep everything on plates, and let them design the experiment. The safety risk is boredom-driven improvisation, not the enzyme.
Rewriting firmware in Rust is fun but the actual reliability win here was the watchdog, which you could have added in C.
Trehalose stabilisation is old but the field-deployment data is what makes this worth reading. 40 °C for six weeks is a real number.
We ran this protocol in our community lab last month. Two of five transformations failed until we dropped the heat shock to 42 s. Worth adding a note.
Teaching teenagers: use non-pathogenic yeast, keep everything on plates, and let them design the experiment. The safety risk is boredom-driven improvisation, not the enzyme.
The border question has no general answer. It is per-country, per-organism, and sometimes per-customs-officer. Talk to the receiving institution first, always.
True, and said so in the README. The Rust part was mostly so contributors stop segfaulting the pH loop.
Started my lab entirely on auction equipment. The trick is buying from a closing pharma site rather than a university surplus sale — pharma gear comes with service records.
Biosafety take: none of this is a problem at BSL-1 with non-pathogenic chassis. The failure mode in community labs is almost never the organism, it is the chemical waste.
We ran this protocol in our community lab last month. Two of five transformations failed until we dropped the heat shock to 42 s. Worth adding a note.
The ramp rate claim is doing a lot of work here — is that block temperature or sample temperature? Those diverge badly above 2 °C/s with thin-wall tubes.
Strongly agree. Our incident log is 90% solvent handling and 10% sharps. Zero biological.
Anyone else notice that the reproducibility argument always ends with "we need better metadata" and never with "we need to fund replication"?
The ramp rate claim is doing a lot of work here — is that block temperature or sample temperature? Those diverge badly above 2 °C/s with thin-wall tubes.
Screening baseline is good but voluntary. Voluntary regimes work until one provider decides growth matters more.
Having done the 50k L version: foam control alone eats the margin they are projecting.
Every time gene therapy pricing comes up someone says "manufacturing" and then nobody funds manufacturing. It is the least glamorous line item in every deck I have seen.
This matches my experience. Also: never buy a -80 freezer sight unseen.
This is the most honest write-up of seed terms I have read. The part about pro-rata rights is the part founders always skip.